The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ROLUPERIDONE ID: ALA4297605
Cas Number: 359625-79-9
PubChem CID: 9799284
Product Number: C176252, Order Now?
Max Phase: Phase
Molecular Formula: C22H23FN2O2
Molecular Weight: 366.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: Roluperidone | FMI | MIN-101 FREE BASE | Roluperidone|359625-79-9|CYR-101|MIN-101|2-((1-(2-(4-fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one|MIN-101 FREE BASE|4P31I0M3BF|Roluperidone (USAN)|ROLUPERIDONE [USAN]|1H-Isoindol-1-one, 2-((1-(2-(4-fluorophenyl)-2-oxoethyl)-4-piperidinyl)methyl)-2,3-dihydro-|2-({1-[2-(4-fluorophenyl)-2-oxoethyl]piperidin-4-yl}methyl)-2,3-dihydro-1H-isoindol-1-one|UNII-4P31I0M3BF|Roluperidon|CYR-101(Roluperidone)|Roluperidone; CYR-101|ROLUPERIDONE [INN]| Show More⌵
Synonyms from Alternative Forms(5): Min-101 | Roluperidone hydrochloride | CYR-101 | CYR-101 HYDROCHLORIDE DIHYDRATE | MT-210
Canonical SMILES: O=C(CN1CCC(CN2Cc3ccccc3C2=O)CC1)c1ccc(F)cc1
Standard InChI: InChI=1S/C22H23FN2O2/c23-19-7-5-17(6-8-19)21(26)15-24-11-9-16(10-12-24)13-25-14-18-3-1-2-4-20(18)22(25)27/h1-8,16H,9-15H2
Standard InChI Key: RNRYULFRLCBRQS-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-5.3243 -0.4069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7368 0.3076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5618 0.3076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.9743 -0.4069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5618 -1.1214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7368 -1.1214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4311 0.5850 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1945 0.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5174 -0.2354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3696 1.7437 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.7139 0.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0022 0.5754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2850 0.9830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0078 -0.2496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2962 -0.6670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5789 -0.2594 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5733 0.5656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8673 -0.6767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1500 -0.2691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1876 0.5551 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5616 -0.6864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2566 -0.2418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5992 -1.5106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3317 -1.8901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0266 -1.4455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9891 -0.6213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7592 -1.8251 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
1 6 1 0
7 8 1 0
7 9 1 0
1 9 1 0
8 2 1 0
8 10 2 0
7 11 1 0
11 12 1 0
14 15 1 0
15 16 1 0
16 17 1 0
13 17 1 0
13 12 1 0
12 14 1 0
16 18 1 0
18 19 1 0
19 20 2 0
19 21 1 0
23 24 1 0
24 25 2 0
25 26 1 0
22 26 2 0
22 21 1 0
21 23 2 0
25 27 1 0
M END
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: YesAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 366.44Molecular Weight (Monoisotopic): 366.1744AlogP: 3.38#Rotatable Bonds: 5Polar Surface Area: 40.62Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.45CX LogP: 2.88CX LogD: 2.84Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: -1.22
References 1. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 2. Unpublished dataset, 3. Fallica AN, Ciaffaglione V, Modica MN, Pittalà V, Salerno L, Amata E, Marrazzo A, Romeo G, Intagliata S.. (2022) Structure-activity relationships of mixed σ1 R/σ2 R ligands with antiproliferative and anticancer effects., 73 [PMID:36202063 ] [10.1016/j.bmc.2022.117032 ]